August 2014 - Volume 24 - Issue 4 - Contributor Index

Kalia, Sunil
Kim, Kevin B.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma

Alrwas, Anas; Papadopoulos, Nicholas E.; Cain, Suzanne; More

Melanoma Research. 24(4):342-348, August 2014.

Kong, Yong

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

Mirjacic Martinovic, Katarina M.; Babovic, Nada Lj.; Džodic, Radan R.; More

Melanoma Research. 24(4):295-304, August 2014.

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Kosiniak-Kamysz, Agnieszka; Marczakiewicz-Lustig, Anna; Marcinska, Magdalena; More

Melanoma Research. 24(4):388-396, August 2014.